{
  "trial_id": "NCT00522405",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Unresectable HCC with underlying Child's A/B cirrhosis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Normal Main portal vein and its branches",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Normal Inferior vena cava",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "No history of drug allergy",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Informed written consent of patient.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Less than 50% involvement of liver by HCC",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Unresectable HCC with underlying Child's C cirrhosis",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Performance status 3-5",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has unresectable HCC with underlying Child's A/B cirrhosis, normal main portal vein and its branches, and informed written consent. However, they have a history of UGIB in the last six months which may be an exclusion criterion.",
  "_meta": {
    "topic_id": "7",
    "trial_id": "NCT00522405",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}